Financial report interval: 2024.12.31 - 2025.12.31
Preview: SHINEWAY PHARM(02877) predict that the Revenue is 3.487 B (-13.25%), Miss estimate;the EBIT is 996.43 M (-8.62%), Beat estimate;the EPS is 1.4 (+18.65%), Beat estimate.